- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT00215111
Role of Carbohydrate Modification in Weight Management Among Obese Children
February 4, 2015 updated by: Shelley Kirk, Ph.D., R.D., L.D., Children's Hospital Medical Center, Cincinnati
The purpose of this study is to test the hypothesis that a low-carbohydrate diet and a low-glycemic load diet will improve body mass index and result in more body fat loss than a control diet among overweight children ages 7 to 12.
In addition this study is also designed to test the safety of diets with modified carbohydrate content as compared to a conventional weight management diet among younger overweight children.
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Detailed Description
The treatment of pediatric obesity supported by the medical community is a moderate restriction in calories by modifying intake of fat and simple sugars, along with an increase in energy expenditure through more physical activity.
However, this approach is associated with only limited success.
As a result, overweight children and adolescents are seeking alternative approaches to weight management, such as diets that modify the type and amount of carbohydrates.
However, at this time there is limited data on the safety and efficacy of these diets, particularly with younger children.
This study is a controlled clinical trial that compares the safety and efficacy of a low carbohydrate and reduced glycemic load diets to a more standard dietary intervention for the management of pediatric obesity (i.e.
portion-controlled, moderate fat, high carbohydrate diet).
This study will involve 150 overweight children (ages 7 to 12) who will be randomly assigned to one of the three diet groups for 12 months.
The effects of each diet will be determined by measuring changes in anthropometric measures (body weight, height, body mass index, waist circumference, body composition), other cardiovascular risk factors (blood pressure, fasting lipid profile, fasting glucose and insulin, and inflammatory markers of cardiovascular disease), and measures of psychological well-being and mental status.
The results of this study will provide needed information to the public in their quest for safe, effective, and health-promoting weight management strategies for obese children.
Such information is vital if we are to address the obesity epidemic in the United States.
Study Type
Interventional
Enrollment (Actual)
102
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Ohio
-
Cincinnati, Ohio, United States, 45229
- Cincinnati Children's Hospital Medical Center
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
7 years to 12 years (Child)
Accepts Healthy Volunteers
Yes
Genders Eligible for Study
All
Description
Inclusion Criteria:
- Age 7-12 years
- Body mass index >95th percentile and BMI z-score no greater than 2.65
- Normal fasting blood glucose of less than 100 mg/dL
- Age-appropriate cognitive and behavioral skills
- Absence of developmental or physical disabilities
- Capability to function independently in group exercise sessions
- Commitment of parent/guardian to attend scheduled meetings for 12-month period
Exclusion Criteria:
- Active cardiac, pulmonary, renal, liver, or gastrointestinal disease (pancreatitis, cholelithiasis, inflammatory bowel disease), diabetes, untreated thyroid disease, hypertension, hyperlipidemia
- Chronic infections
- Uncompensated or labile mental illness
- Chronic or intermittent use of corticosteroids
- Specific medications that may alter lipid, glucose, bone metabolism or appetite
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: Low carbohydrate, reduced glycemic load, control diet
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Time Frame |
|---|---|
|
The outcomes listed below will be obtained at baseline,3-month,
Time Frame: 3 month
|
3 month
|
|
6-month and 12-month assessments unless otherwise noted,body weight,
Time Frame: 6-month and 12-month
|
6-month and 12-month
|
|
height,body mass index,waist circumference,percent body fat,
Time Frame: baseline, 3-month, 6-month and 12-month
|
baseline, 3-month, 6-month and 12-month
|
|
adipose mass,lean body mass,bone mineral density,fasting lipid profile,
Time Frame: baseline, 3-month, 6-month and 12-month
|
baseline, 3-month, 6-month and 12-month
|
|
fasting insulin,fasting glucose,2-hour glucose (baseline and 3-month assessment),
Time Frame: baseline, 3-month, 6-month and 12-month
|
baseline, 3-month, 6-month and 12-month
|
Secondary Outcome Measures
Outcome Measure |
Time Frame |
|---|---|
|
physical activity (3-day physical activity records and pedometer readings)
Time Frame: 3-month, 6-month and 12-month
|
3-month, 6-month and 12-month
|
|
compliance with behavioral intervention (frequency rewards were earned)
Time Frame: weekly
|
weekly
|
|
attendance at group and individual sessions during initial 3-month intervention
Time Frame: 3-month, 6-month and 12-month
|
3-month, 6-month and 12-month
|
|
Sexual Maturity Rating
Time Frame: baseline
|
baseline
|
|
Hunger/Satiety assessment (Three-Factor Eating Questionnaire)
Time Frame: baseline, 3-month, 6-month and 12-month
|
baseline, 3-month, 6-month and 12-month
|
|
Parent/guardian perception of success for each diet assignment prior to their child being randomized to a diet group
Time Frame: baseline
|
baseline
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Collaborators
Investigators
- Principal Investigator: Shelley Kirk, Ph.D., R.D., Children's Hospital Medical Center, Cincinnati
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start
March 1, 2005
Primary Completion (Actual)
June 1, 2008
Study Completion (Actual)
June 1, 2008
Study Registration Dates
First Submitted
September 15, 2005
First Submitted That Met QC Criteria
September 15, 2005
First Posted (Estimate)
September 22, 2005
Study Record Updates
Last Update Posted (Estimate)
February 5, 2015
Last Update Submitted That Met QC Criteria
February 4, 2015
Last Verified
February 1, 2015
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- 02819-8
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Childhood Obesity
-
Universiteit LeidenWageningen University; Nutricia, Inc.; Danone ResearchCompletedChildhood Obesity | Childhood Overweight | Vegetable Acceptance in Early ChildhoodNetherlands
-
Cornell UniversityCompletedChildhood Obesity Prevention
-
Universidad de SonoraCentro de Investigación en Alimentación y Desarrollo A.C.; Instituto Nacional...Not yet recruitingChildhood Obesity Pevention
-
Tehran University of Medical SciencesUnknownChildhood Obesity PreventionIran, Islamic Republic of
-
Universidad Autonoma de Nuevo LeonUniversidad de la SabanaCompletedPrevention Childhood ObesityMexico
-
Oregon State UniversityCompletedChildhood Obesity Prevention
-
The Miriam HospitalHassenfeld Child Health Innovation InstituteCompletedChildhood Obesity PreventionUnited States
-
Fundacion para la Formacion e Investigacion Sanitarias...UnknownChildhood Obesity PreventionSpain
-
Tampere UniversitySeinajoki Central Hospital; Tampere University Hospital; Foundation for Paediatric... and other collaboratorsCompleted
-
Harokopio UniversityCompletedPrevention of Childhood ObesityGreece
Clinical Trials on Low carbohydrate, reduced glycemic load, and a control diet
-
Queen's UniversityTerminatedObesity | Cardiovascular Disease | Metabolic SyndromeCanada
-
Universidad Autonoma de Baja CaliforniaTerminated
-
Robert C. Atkins FoundationCompletedObesity | Overweight | Type 2 Diabetes MellitusUnited States
-
Rhode Island HospitalCystic Fibrosis FoundationRecruitingCystic Fibrosis | Cystic Fibrosis-related Diabetes | Cystic Fibrosis With Intestinal ManifestationsUnited States
-
Boston Children's HospitalCompletedCystic Fibrosis | Cystic Fibrosis-related Diabetes | Cystic Fibrosis With Intestinal ManifestationsUnited States
-
Boston Children's HospitalNational Institute of Diabetes and Digestive and Kidney Diseases (NIDDK); Charles...Completed
-
Charite University, Berlin, GermanyCompletedRelapsing-Remitting Multiple SclerosisGermany
-
Fred Hutchinson Cancer CenterNational Cancer Institute (NCI)Completed
-
Boston Children's HospitalNational Institute of Diabetes and Digestive and Kidney Diseases (NIDDK); Beth... and other collaboratorsCompleted
-
University of Alabama at BirminghamEunice Kennedy Shriver National Institute of Child Health and Human Development...CompletedPolycystic Ovary SyndromeUnited States